On August 15, HUKUI participated in the 815 International Life Science · Brand Finance Summit 2026, joining leaders and experts from industry, government, academia, research, healthcare, and international organizations to exchange perspectives on the future of life sciences, smart healthcare, and global development.
Under the theme “From Innovation to IPO,” the summit explored key areas including life sciences, smart healthcare, intellectual property, brand finance, and international collaboration, creating a cross-sector platform that connects innovation with real-world applications and global opportunities.
During the event, HUKUI also showcased its "Forty+40 Gamma Light", providing an opportunity to exchange insights on smart lighting and technology applications with leaders across the healthcare sector. We were pleased to engage with distinguished guests, including Taiwan’s Minister of Health and Welfare Dr. Chung-Liang Shih and former Director General of the Department of Health Shiing-Jer Twu, fostering meaningful dialogue around healthcare innovation and emerging technologies.
Meanwhile, HUKUI Co-Founder and CEO Michael Kuo represented the company in advancing the vision of cross-sector and international collaboration and joined relevant partners in signing a Memorandum of Understanding (主題標籤#MOU), opening new opportunities for future exchange and collaboration across life sciences and smart healthcare.
At HUKUI, we believe the value of medical innovation lies in turning ideas into validated, manufacturable, scalable, and market-ready solutions. As a 主題標籤#CDMO specializing in medical electronics and smart medical devices, we integrate R&D, engineering, regulatory support, and manufacturing capabilities to help bridge the gap from concept to commercialization.
We look forward to strengthening connections across healthcare, technology, and industry — creating greater possibilities for smart healthcare worldwide.
Make Science Felt.